Navigation Links
InVitria Presents Zap-CHO Performance Results at PEACe Conference
Date:9/23/2009

Zap-CHO: a new and innovative CHO cell culture supplement from InVitria designed to deliver superior growth, maximum antibody productivity and faster cell line development. Performance results were presented to attendees of the PEACe Conference in Jackson Hole, WY this week.

Fort Collins, CO September 23, 2009 / b3c newswire / C A new powerful and robust cell culture supplement for CHO (Chinese hamster ovaries) cell line enhancement called Zap-CHO was featured this week at the 9th Protein Expression in Animal Cells (PEACe) Conference in Jackson Hole, Wyoming.
Zap-CHO is a significant breakthrough in mammalian cell culture systems, said Dr. Steve Pettit, InVitrias Director of Cell Culture Development. With the development of Zap-CHO, InVitria has created a performance enhancing CHO media supplement that is the first animal free supplement capable of replacing fetal bovine serum (FBS) without sacrificing performance and maintaining a well defined media. Since Zap-CHO is a defined and animal component-free product, it is well suited for commercial, chemically-defined and serum- and animal-free cell culture media formulations, said Dr. Pettit.
Dr. Pettit presented the Zap-CHO performance results during the technical workshop and he also presented during the poster session at PEACe on Tuesday. Copies of the poster and presentation are available by contacting InVitria at the email address or phone number listed below.
Zap-CHO is a next generation media supplement that delivers consistent cell culture performance. Previously, only FBS could deliver equivalent performance, but safety concerns of a fetal bovine component in cell culture media forced many customers away from this component. In the last decade, customers have eliminated FBS in cell culture media only to lose cell culture performance. To regain the lost performance, many began adding hydrolysates to the media. However, hydrolysates introduced significant variability, leading to failed experiments and production failures. Zap-CHO addresses these concerns and provides significant benefits in CHO cell culture, including:
*Faster cell line development and seed train expansion
*Animal component-free media
*Consistency of a defined media component
*Biomanufacturing optimization and improved production economics
*Better and more predictable performance in cell culture research and development
Now, with Zap-CHO, customers can get the animal free benefit of hydrolysates, the performance of FBS and the consistency of a defined media, said Randy Semadeni, InVitrias Vice President of Business Development. It is a new era for the cell culture industry.


About InVitria - www.InVitria.com
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media components and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.


For more information about InVitrias products or to obtain a copy of Dr. Pettits Zap-CHO poster or presentation, please contact InVitria at info@invitria.com or call 1-800-916-8311.


'/>"/>
b3c newswire

Related biology news :

1. InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture
2. InVitria Sponsors ESACT 2009 in Dublin, Ireland
3. InVitria to Unveil Powerful Cell Culture Media Component ZAP-CHO
4. InVitria Announces Launch of Recombinant Albumin for Diagnostics
5. The BBVA Foundation presents its Frontiers of Knowledge Awards
6. Versartis presents positive preclinical data on 2 product candidates at ENDO 09
7. REGiMMUNE presents enhanced efficacy data in preclinical transplantation models
8. Biolex presents Locteron US Phase 2a hepatitis C data at EASL
9. GSA special paper presents new studies of Western US earth motion
10. AIUM Presents 2009 Joseph H. Holmes Pioneer Awards
11. AIUM presents 2009 Memorial Hall of Fame awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/27/2016)... , Jan. 27, 2016  Rite Track, Inc. ... in West Chester, Ohio announced ... winning service staff, based in Austin, Texas ... and ability to provide modifications, installations and technical support ... , CEO of PLUS, commented, "PLUS has provided world ...
(Date:1/22/2016)... , January 22, 2016 ... the addition of the  "Global Behavioral ... offering. --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) ... "Global Behavioral Biometric Market 2016-2020"  report ... Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has ...
(Date:1/20/2016)... 20, 2016 A market that just keeps ... from the explosion in genomics knowledge. Learn all about ... A range of dynamic trends are pushing market growth ... medicine - pharmacogenomics - pathogen evolution - next generation ... - greater understanding of the role of genetic material ...
Breaking Biology News(10 mins):
(Date:2/9/2016)... ... February 09, 2016 , ... PharmApprove announced ... the National Organization for Rare Disorders (NORD). Dorman will lead PharmApprove efforts to ... heard throughout the drug regulatory review process. , “Adding Diane Dorman is just ...
(Date:2/9/2016)... YORK , Feb. 9, 2016 This ... analyzes the current and future prospects of the market ... this report include companies engaged in the manufacture of ... an executive summary with a market snapshot providing the ... scope of this report. This section also provides the ...
(Date:2/9/2016)... Three-Year Initiative Supports Next Generation of Medical Geneticists and  ... Experiences SHPG ) ... of children born with rare diseases, as well as the future ... a new initiative designed to positively affect the lives of children ... disease care. --> To mark the company,s founding 30 ...
(Date:2/9/2016)... , Feb. 9, 2016 ... Inhibitors-Pipeline Insights, 2016", report provides in depth ... development activities around the Protein-Tyrosine Phosphatase 1B ... product profiles in various stages of development ... II, Phase III and Preregistration. Report covers ...
Breaking Biology Technology: